Statistics in the era of COVID-19: Measuring lockdowns with doubling time

graph and clock design

The key to understanding SARS-CoV-2 (COVID-19) transmission is understanding the exponential growth of viral transmissions. The problem is that the concept of exponential growth is challenging for many to understand and interpret, including policymakers who need to make quick and informed decisions. Dr Biljana Stangeland, Executive Director/Chief Scientific Officer at Alv B, Norway, has been using doubling time – the […]

Read More…

The unwanted tenant: Parasitic nematodes in Aboriginal communities

Representation of Larvae migrating via the bloodstream

  Strongyloides stercoralis and HTLV-I are endemic pathogens that impact millions of people worldwide, particularly those in socioeconomically deprived communities. Dr Catherine Gordon and her team, led by NHMRC Leadership Fellow Professor Don McManus at QIMR Berghofer in Brisbane, Australia, summarise the current data on S. stercoralis and HTLV-I infections in Tropical Australia, and advocate for the inclusion of Strongyloides […]

Read More…

Geovisualization for insights into infectious disease risk

Geovisualization for insights into infectious disease risk

Environmental, social, and economic factors influence infectious disease transmission and resulting risk. Using exploratory data analysis techniques can help uncover previously unknown relationships between these factors, contributing to improved public health efforts. Drs Abhishek Kala, Samuel Atkinson, and Chetan Tiwari from the University of North Texas, USA, use geovisualization to identify the spatial context and factors that are strongly associated […]

Read More…

How treatment epidemiology can shape future healthcare research

How treatment epidemiology can shape future healthcare researc

Dr Aisling Caffrey is an Associate Professor of Health Outcomes at the College of Pharmacy, University of Rhode Island. For over a decade, Dr Caffrey has been studying the treatment of diseases in real-world clinical practice, an area Dr Caffrey has termed ‘treatment epidemiology’. Dr Caffrey’s expertise is in comparative effectiveness and safety research, where she studies the benefits and harms of healthcare interventions, […]

Read More…

Integrating molecular epidemiology and microbiome science
How cancer patients respond to therapy

Integrating molecular epidemiology and microbiome science How cancer patients respond to therapy

Understanding the variation in responses to cancer therapeutics would create better treatment for many patients and provide an important basis for further research into new or personalised treatments. It is understood there is a connection between patient response to treatment and their microbiome. However, there is currently a lack of consensus on the microbial signatures present in responsive versus unresponsive […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION